Seek Labs and NAMRU EURAFCENT Enter CRADA to Evaluate Field-Deployable Diagnostics for Infectious Diseases
SALT LAKE CITY, Aug. 24, 2026 (GLOBE NEWSWIRE) — Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases, today announced a Cooperative Research and Development Agreement (CRADA) with the Naval Medical Research Unit (NAMRU) EURAFCENT, part of Navy Medicine Research & Development that is focused on infectious disease threats […]
Financial Post
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from Financial Post.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
Financial Post (financialpost.com), a Tier B publisher, filed this report on . CurrentWire published this page 1 hour later, on .
Signal breakdown
CurrentWire ranked this story 50 of 100 in the snapshot this page was rendered from.
- Freshness
- 29 of 35
- Source authority
- 7 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 6.5 of 10
- Velocity
- 0 of 5
Strongest signal: freshness, 29 of 35. How each signal is calculated.
Filed under Health · International · Press release. Topics extracted from this report, with other live CurrentWire stories mentioning each: NAMRU EURAFCENT Enter CRADA (none), Evaluate Field-Deployable Diagnostics (none), Infectious Diseases (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.